Opaleye Management’s Aratana Therapeutics PETX Stock Holding History
Bought
Maintained
Sold
Other funds holding PETX
AIC
Opaleye Management's PETX Position: Q4 2017 in Review
Opaleye Management sold out of Aratana Therapeutics (PETX) in Q4 2017, closing a stake of 420,000 shares — an estimated $2.57M sold.
Opaleye Management first reported a position in PETX in Q2 2017 and held it in 2 quarters. The position peaked at $2.57M in Q3 2017. 105 funds tracked by Wall St. Rank hold PETX as of Q4 2017.
- Opaleye Management reported no remaining Aratana Therapeutics position as of Q4 2017 after selling out during the quarter.
- Opaleye Management sold 420,000 Aratana Therapeutics shares in Q4 2017, an estimated $2.57M.
- Opaleye Management first reported a position in Aratana Therapeutics in Q2 2017 and held it in 2 quarters.
- Opaleye Management's Aratana Therapeutics position peaked at $2.57M in Q3 2017.
- 105 funds tracked by Wall St. Rank held Aratana Therapeutics as of Q4 2017.
Based on Opaleye Management's 13F filing for Q4 2017, filed 9 Feb 2018.